Kurt A. Gustafson - 15 Mar 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: N/A
Reported as of: 15 Mar 2022
Net transaction value: -$26,081
SEC form: 4
Accepted by SEC: 16 Mar 2022, 18:15:45 UTC
Prior SEC filing: 24 Feb 2022
Next SEC filing: 27 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Kurt A. Gustafson

Key filing fact

Kurt A. Gustafson filed Form 4 for SPECTRUM PHARMACEUTICALS INC on 16 Mar 2022.

Key facts

This page summarizes Kurt A. Gustafson's Form 4 filing for SPECTRUM PHARMACEUTICALS INC.
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 16 Mar 2022, 18:15.

Change

Previous filing in this sequence was filed on 24 Feb 2022.
Current net transaction value: -$26,081.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPPI transaction

Common Stock, $0.001 par value

Sale

Transaction value: $14,560
Shares: -20,653
Change %: -5.8%
Price: $0.7050
Shares after: 333,577
Date: 15 Mar 2022
Ownership: Direct
Footnotes: F1

SPPI transaction

Common Stock, $0.001 par value

Sale

Transaction value: $11,521
Shares: -16,318
Change %: -4.9%
Price: $0.7060
Shares after: 317,259
Date: 16 Mar 2022
Ownership: Direct
Footnotes: F1

SPPI holding

Common Stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,840
Date: 15 Mar 2022
Ownership: By 401(k) Plan

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.